Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients.

Autor: Jankowitz, R. C., Brufsky, A. M.
Předmět:
Zdroj: Breast Diseases: A Year Book Quarterly; Jan-Mar2010, Vol. 20 Issue 4, p422-424, 3p, 2 Graphs
Abstrakt: The article discusses research on the effect of trastuzumab on brain metastasis (BM) outcomes in patients with HER2-overexpressing metastatic breast cancer (MBC). It references the study "Trastuzumab Treatment Improves Brain Metastasis Outcomes Through Control and Durable Prolongation of Systemic Extracranial Disease in HER2-Overexpressing Breast Cancer Patients," by Y. H. Park and colleagues, published in a 2009 issue of "British Journal of Cancer." It is said that trastuzumab imposes a delaying effect on the involvement of the central nervous system.
Databáze: Supplemental Index